In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 25, No. 7 ( 2005-07), p. 1433-1438
Abstract:
Here we describe the application of RNA interference in vivo by using an adenoviral vector to elucidate the liver-specific role of ABCA1 with regard to its influence on systemic lipoprotein metabolism. Knockdown of hepatic ABCA1 leads to a reduction of both plasma HDL levels and postprandial lipemia.
Type of Medium:
Online Resource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/01.ATV.0000166616.86723.d0
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2005
detail.hit.zdb_id:
1494427-3
Permalink